Toshio Miyashita
Financieel Directeur/CFO bij SOLASIA PHARMA K.K.
Vermogen: 82 164 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Toshio Miyashita
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Toshio Miyashita via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ITOCHU CORPORATION | Food Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| GLAND PHARMA LIMITED | Pharmaceuticals: Major | Chairman Chairman | |
| University of London | College/University | Undergraduate Degree Undergraduate Degree | |
| Tokyo University of Pharmacy & Life Science | College/University | Graduate Degree | |
LTL Pharma Co., Ltd.
 LTL Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology LTL Pharma Co., Ltd. is a pharmaceutical company founded in 2016 and based in Tokyo, Japan. The Japanese company specializes in long-term products and aims to provide reliable and effective products to patients. The company's website includes a product list page that is limited to medical professionals. LTL Pharma actively seeks business alliances with other companies both domestically and overseas. The company's top management greetings are also available on their website. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ITOCHU CHEMICAL FRONTIER Corp.
 ITOCHU CHEMICAL FRONTIER Corp. Wholesale DistributorsDistribution Services Part of ITOCHU Corp., ITOCHU CHEMICAL FRONTIER Corp. is a Japanese company that imports and markets allied chemicals. The company is based in Tokyo, Japan. | Wholesale Distributors | Director/Board Member | |
| PTAGENT Corp. Co., Ltd. | Corporate Officer/Principal | ||
Beijing ITOCHU-Huatang Comprehensive Processing Co., Ltd.
 Beijing ITOCHU-Huatang Comprehensive Processing Co., Ltd. Wholesale DistributorsDistribution Services Part of ITOCHU Corp., Beijing ITOCHU-Huatang Comprehensive Processing Co., Ltd. engages in general wholesale business of cosmetics, daily commodities, and sundries. The company is based in Beijing, China. | Wholesale Distributors | Director/Board Member | |
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
| FUNPEP COMPANY LIMITED | Biotechnology | Director/Board Member | |
| TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
| Searle Yakuhin KK | Corporate Officer/Principal | ||
| University of Wales (Bangor) | College/University | Masters Business Admin | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Keio University | College/University | Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
Shenzhen Tailai Biotechnology Co., Ltd.
 Shenzhen Tailai Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Tailai Biotechnology Co., Ltd. is a Chinese company that specializes in the research and development of cancer screening products and services. The company is based in Shenzhen, China. and has subsidiaries in China. Yiu Kwan Lau has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
Baxter (China) Investment Co. Ltd.
 Baxter (China) Investment Co. Ltd. Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter (China) Investment Co. Ltd. provides investment services. The company is based in Shanghai, China. | Financial Conglomerates | Corporate Officer/Principal | |
| MEDSCI HEALTHCARE HOLDINGS LIMITED | Medical/Nursing Services | Director/Board Member | |
Xi'an Libang Pharmaceutical Co. Ltd.
 Xi'an Libang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Xi'an Libang Pharmaceutical Co. Ltd. is a private company that develops, produces, and distributes pharmaceutical products. The company is based in Xi'an, China. | Pharmaceuticals: Major | Director/Board Member | |
| BizPro International LLC | Corporate Officer/Principal | ||
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Eddingpharm (Cayman), Inc.
 Eddingpharm (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong. | Pharmaceuticals: Major | Chief Operating Officer | |
| Amsino Medical | Chief Executive Officer | ||
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Consultant / Advisor |
Statistieken
Internationaal
| Japan | 12 |
| China | 8 |
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 3 |
| India | 2 |
Sectoraal
| Health Technology | 13 |
| Consumer Services | 5 |
| Distribution Services | 4 |
| Finance | 4 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 17 |
| Corporate Officer/Principal | 12 |
| Independent Dir/Board Member | 9 |
| Chairman | 5 |
| Undergraduate Degree | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Yiu Kwan Lau | 12 |
| Yoshihiro Arai | 5 |
| Norikazu Eiki | 5 |
| Tajio Enoki | 5 |
| Koji Shinozaki | 4 |
| Stanley Lau | 4 |
| Yasuhiro Abe | 2 |
| Jiro Mizukawa | 2 |
| Yasumitsu Shimada | 1 |
| Yasuaki Manabe | 1 |
- Beurs
- Insiders
- Toshio Miyashita
- Bedrijfsconnecties
